Dalbavancin Injection, Powder, For Solution
Product Images NDC 0480-3325

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dalbavancin (NDC 0480-3325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Dalbavancin Structural Formula (Dalbavancin For Injection A219465 1)

Chemical structure of Dalbavancin showing its molecular composition and arrangement, including various functional groups and atoms labeled with R1 and R2 side chains and a 1.6 HCl notation.*

FDA Label Image

Carton (Dalbavancin For Injection A219465 2)

Packaging label for Dalbavancin 500 mg per vial, injection powder for solution. The label states it is for intravenous infusion only, single-dose vial. Produced by Teva Pharmaceuticals, Inc., it includes storage instructions, dosage form, and manufacturer details. The label specifies Rx only and provides NDC 0480-3325-01 on various panels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.